Follow
Zohreh Varasteh
Zohreh Varasteh
Ph.D. Research fellow
Verified email at tum.de
Title
Cited by
Cited by
Year
Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labeled fibroblast activation protein inhibitor, FAPI-04
Z Varasteh, S Mohanta, S Robu, M Braeuer, Y Li, N Omidvari, G Topping, ...
Journal of Nuclear Medicine 60 (12), 1743-1749, 2019
1742019
Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 111In-tilmanocept
Z Varasteh, F Hyafil, N Anizan, D Diallo, R Aid-Launais, S Mohanta, Y Li, ...
EJNMMI research 7, 1-9, 2017
882017
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification
M Malm, N Kronqvist, H Lindberg, L Gudmundsdotter, T Bass, FY Frejd, ...
Plos one 8 (5), e62791, 2013
812013
Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging
Z Varasteh, I Velikyan, G Lindeberg, J Sorensen, M Larhed, M Sandstrom, ...
Bioconjugate chemistry 24 (7), 1144-1153, 2013
782013
The effect of mini-PEG-based spacer length on binding and pharmacokinetic properties of a 68Ga-labeled NOTA-conjugated antagonistic analog of bombesin
Z Varasteh, U Rosenström, I Velikyan, B Mitran, M Altai, H Honarvar, ...
Molecules 19 (7), 10455-10472, 2014
742014
Imaging of platelet-derived growth factor receptor β expression in glioblastoma xenografts using affibody molecule 111In-DOTA-Z09591
V Tolmachev, Z Varasteh, H Honarvar, SJ Hosseinimehr, O Eriksson, ...
Journal of Nuclear Medicine 55 (2), 294-300, 2014
632014
The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26
Z Varasteh, B Mitran, U Rosenström, I Velikyan, M Rosestedt, ...
Nuclear medicine and biology 42 (5), 446-454, 2015
612015
Imaging of HER3-expressing xenografts in mice using a 99mTc(CO)3-HEHEHE-ZHER3:08699 affibody molecule
A Orlova, M Malm, M Rosestedt, Z Varasteh, K Andersson, RK Selvaraju, ...
European journal of nuclear medicine and molecular imaging 41, 1450-1459, 2014
562014
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in …
J Malmberg, A Perols, Z Varasteh, M Altai, A Braun, M Sandström, ...
European journal of nuclear medicine and molecular imaging 39, 481-492, 2012
562012
Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo
J Strand, Z Varasteh, O Eriksson, L Abrahmsen, A Orlova, V Tolmachev
Molecular pharmaceutics 11 (11), 3957-3964, 2014
542014
In Vitro and In Vivo Evaluation of a 18F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
Z Varasteh, O Åberg, I Velikyan, G Lindeberg, J Sörensen, M Larhed, ...
PloS one 8 (12), e81932, 2013
532013
Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04
S Notohamiprodjo, SG Nekolla, S Robu, AV Asiares, C Kupatt, T Ibrahim, ...
Journal of Nuclear Cardiology 29 (5), 2254-2261, 2022
482022
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
A Orlova, C Hofström, J Strand, Z Varasteh, M Sandstrom, K Andersson, ...
European journal of nuclear medicine and molecular imaging 40, 439-449, 2013
462013
In Vivo and In Vitro Studies on Renal Uptake of Radiolabeled Affibody Molecules for Imaging of HER2 Expression in Tumors
M Altai, Z Varasteh, K Andersson, A Eek, O Boerman, A Orlova
Cancer Biotherapy and Radiopharmaceuticals 28 (3), 187-195, 2013
432013
Bispecific GRPR-antagonistic anti-PSMA/GRPR heterodimer for PET and SPECT diagnostic imaging of prostate cancer
B Mitran, Z Varasteh, A Abouzayed, SS Rinne, E Puuvuori, M De Rosa, ...
Cancers 11 (9), 1371, 2019
372019
Comparative evaluation of 111In-labeled NOTA‑conjugated affibody molecules for visualization of HER3 expression in malignant tumors
KG Andersson, M Rosestedt, Z Varasteh, M Malm, M Sandström, ...
Oncology Reports 34 (2), 1042-1048, 2015
372015
Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26
B Mitran, Z Varasteh, RK Selvaraju, G Lindeberg, J Sörensen, M Larhed, ...
International journal of oncology 48 (5), 2124-2134, 2016
332016
188Re-ZHER2: V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment
M Altai, H Wållberg, H Honarvar, J Strand, A Orlova, Z Varasteh, ...
Journal of Nuclear Medicine 55 (11), 1842-1848, 2014
292014
Heterodimeric radiotracer targeting PSMA and GRPR for imaging of prostate cancer—Optimization of the affinity towards PSMA by linker modification in murine model
F Lundmark, A Abouzayed, B Mitran, SS Rinne, Z Varasteh, M Larhed, ...
Pharmaceutics 12 (7), 614, 2020
262020
Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with 188Re
M Altai, H Honarvar, H Wållberg, J Strand, Z Varasteh, M Rosestedt, ...
European Journal of Medicinal Chemistry 87, 519-528, 2014
262014
The system can't perform the operation now. Try again later.
Articles 1–20